These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21702452)

  • 1. Conjugation of cRGD peptide to chlorophyll a based photosensitizer (HPPH) alters its pharmacokinetics with enhanced tumor-imaging and photosensitizing (PDT) efficacy.
    Srivatsan A; Ethirajan M; Pandey SK; Dubey S; Zheng X; Liu TH; Shibata M; Missert J; Morgan J; Pandey RK
    Mol Pharm; 2011 Aug; 8(4):1186-97. PubMed ID: 21702452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative tumor imaging and PDT Efficacy of HPPH conjugated in the mono- and di-forms to various polymethine cyanine dyes: part - 2.
    James NS; Ohulchanskyy TY; Chen Y; Joshi P; Zheng X; Goswami LN; Pandey RK
    Theranostics; 2013; 3(9):703-18. PubMed ID: 24019855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlorophyll-a analogues conjugated with aminobenzyl-DTPA as potential bifunctional agents for magnetic resonance imaging and photodynamic therapy.
    Li G; Slansky A; Dobhal MP; Goswami LN; Graham A; Chen Y; Kanter P; Alberico RA; Spernyak J; Morgan J; Mazurchuk R; Oseroff A; Grossman Z; Pandey RK
    Bioconjug Chem; 2005; 16(1):32-42. PubMed ID: 15656573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photosensitizer (PS)-cyanine dye (CD) conjugates: Impact of the linkers joining the PS and CD moieties and their orientation in tumor-uptake and photodynamic therapy (PDT).
    James NS; Joshi P; Ohulchanskyy TY; Chen Y; Tabaczynski W; Durrani F; Shibata M; Pandey RK
    Eur J Med Chem; 2016 Oct; 122():770-785. PubMed ID: 27543778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) in a nude rat glioma model: implications for photodynamic therapy.
    Lobel J; MacDonald IJ; Ciesielski MJ; Barone T; Potter WR; Pollina J; Plunkett RJ; Fenstermaker RA; Dougherty TJ
    Lasers Surg Med; 2001; 29(5):397-405. PubMed ID: 11891727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.
    Bellnier DA; Greco WR; Loewen GM; Nava H; Oseroff AR; Pandey RK; Tsuchida T; Dougherty TJ
    Cancer Res; 2003 Apr; 63(8):1806-13. PubMed ID: 12702566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjugation of 2-(1'-hexyloxyethyl)-2-devinylpyropheophorbide-a (HPPH) to carbohydrates changes its subcellular distribution and enhances photodynamic activity in vivo.
    Zheng X; Morgan J; Pandey SK; Chen Y; Tracy E; Baumann H; Missert JR; Batt C; Jackson J; Bellnier DA; Henderson BW; Pandey RK
    J Med Chem; 2009 Jul; 52(14):4306-18. PubMed ID: 19507863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole body and local hyperthermia enhances the photosensitizing efficacy of 3-[(1'-hexyloxy)ethyl]-3-Devinylpyropheophorbide-a (HPPH).
    Srivatsan A; Sen A; Cheruku RR; Missert JR; Durrani FA; Guru K; Pandey RK
    Lasers Surg Med; 2018 Jul; 50(5):506-512. PubMed ID: 29737551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cRGD Peptide-Conjugated Pyropheophorbide-a Photosensitizers for Tumor Targeting in Photodynamic Therapy.
    Li W; Tan S; Xing Y; Liu Q; Li S; Chen Q; Yu M; Wang F; Hong Z
    Mol Pharm; 2018 Apr; 15(4):1505-1514. PubMed ID: 29502410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization and treatment of transformed tissues using the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a.
    Furukawa K; Yamamoto H; Crean DH; Kato H; Mang TS
    Lasers Surg Med; 1996; 18(2):157-66. PubMed ID: 8833284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel methods to incorporate photosensitizers into nanocarriers for cancer treatment by photodynamic therapy.
    Wang S; Fan W; Kim G; Hah HJ; Lee YE; Kopelman R; Ethirajan M; Gupta A; Goswami LN; Pera P; Morgan J; Pandey RK
    Lasers Surg Med; 2011 Sep; 43(7):686-95. PubMed ID: 22057496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Structures of Gd(III) Chelates Conjugated at the Periphery of 3-(1'-Hexyloxy)ethyl-3-devinylpyropheophorbide-a (HPPH) Have a Significant Impact on the Imaging and Therapy of Cancer.
    Zhang S; Cheruku RR; Dukh M; Tabaczynski W; Patel NJ; White WH; Missert JR; Spernyak JA; Pandey RK
    ChemMedChem; 2020 Nov; 15(21):2058-2070. PubMed ID: 32916033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate affinity of photosensitizers derived from chlorophyll-a: the ABCG2 transporter affects the phototoxic response of side population stem cell-like cancer cells to photodynamic therapy.
    Morgan J; Jackson JD; Zheng X; Pandey SK; Pandey RK
    Mol Pharm; 2010 Oct; 7(5):1789-804. PubMed ID: 20684544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of Tumor-avid Photosensitizer-Gd(III)DTPA conjugates: impact of the number of gadolinium units in T1/T2 relaxivity, intracellular localization, and photosensitizing efficacy.
    Goswami LN; White WH; Spernyak JA; Ethirajan M; Chen Y; Missert JR; Morgan J; Mazurchuk R; Pandey RK
    Bioconjug Chem; 2010 May; 21(5):816-27. PubMed ID: 20387863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-Avid 3-(1'-Hexyloxy)ethyl-3-devinylpyrpyropheophorbide-a (HPPH)-3Gd(III)tetraxetan (DOTA) Conjugate Defines Primary Tumors and Metastases.
    Cheruku RR; Turowski SG; Durrani FA; Tabaczynski WA; Cacaccio J; Missert JR; Curtin L; Sexton S; Alberico R; Hendler CM; Spernyak JA; Grossman Z; Pandey RK
    J Med Chem; 2022 Jul; 65(13):9267-9280. PubMed ID: 35763292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging a photodynamic therapy photosensitizer in vivo with a time-gated fluorescence tomography system.
    Mo W; Rohrbach D; Sunar U
    J Biomed Opt; 2012 Jul; 17(7):071306. PubMed ID: 22894467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetic modeling and simulation of HPPH in Chinese patients with esophageal carcinoma.
    Chen L; Ye X; Hu K; Zhai Y; Li W; Wang X; Yang J
    Xenobiotica; 2020 Feb; 50(2):170-177. PubMed ID: 30901299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gap junction enhances phototoxicity of photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinylpyropheophorbide-a (HPPH).
    Liu Z; Wang Q; Fan L; Wu DP; Zhang Y; Liu L; Tao L
    Lasers Surg Med; 2015 Jan; 47(1):68-76. PubMed ID: 25483871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Core-shell polymeric nanoparticles co-loaded with photosensitizer and organic dye for photodynamic therapy guided by fluorescence imaging in near and short-wave infrared spectral regions.
    Chepurna OM; Yakovliev A; Ziniuk R; Nikolaeva OA; Levchenko SM; Xu H; Losytskyy MY; Bricks JL; Slominskii YL; Vretik LO; Qu J; Ohulchanskyy TY
    J Nanobiotechnology; 2020 Jan; 18(1):19. PubMed ID: 31973717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effects of photodynamic therapy with HPPH and gemcitabine in pancreatic cancer cell lines.
    Sun G; Anderson MA; Gorospe EC; Leggett CL; Lutzke LS; Wong Kee Song LM; Levy M; Wang KK
    Lasers Surg Med; 2012 Nov; 44(9):755-61. PubMed ID: 23018618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.